Not to sure where you feel the financials are not looking good? From last look they had over $150m in cash not to mention the re-occuring revenue from servicing the contracts coming in and the new contract wins. As IBA has completely designed and integrated their platfrom for asia, they will inturn be able to integrate parts of this into Lorenzo and eliminate many of the costs involved.
If you have a look also at the AGM from november they have already stated that their operational cash was over 100% of earnings and 60% of its earnings and now recurring. Also they have already achieved 31% of their cost synergies for the integration which is a FY09 target. Fundamentally now that the isoft deal is fully funded, there are no 'credit crunch' issues as they have already funded it so once the market gets out of the digestion phase the stock should go
IBA
iba health group limited
it is such a gamble but then..., page-4
Add to My Watchlist
What is My Watchlist?